These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9815574)

  • 41. Hel-N1, an RNA-binding protein, is a ligand for an A + U rich region of the GLUT1 3' UTR.
    Jain RG; Andrews LG; McGowan KM; Gao F; Keene JD; Pekala PP
    Nucleic Acids Symp Ser; 1995; (33):209-11. PubMed ID: 8643372
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A developmental model of neuroblastoma: differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage.
    Hoehner JC; Gestblom C; Hedborg F; Sandstedt B; Olsen L; Påhlman S
    Lab Invest; 1996 Nov; 75(5):659-75. PubMed ID: 8941212
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cross-study analysis of gene expression data for intermediate neuroblastoma identifies two biological subtypes.
    Warnat P; Oberthuer A; Fischer M; Westermann F; Eils R; Brors B
    BMC Cancer; 2007 May; 7():89. PubMed ID: 17531100
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastomas.
    Tang XX; Evans AE; Zhao H; Cnaan A; London W; Cohn SL; Brodeur GM; Ikegaki N
    Clin Cancer Res; 1999 Jun; 5(6):1491-6. PubMed ID: 10389937
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activity-dependent expression of ELAV/Hu RBPs and neuronal mRNAs in seizure and cocaine brain.
    Tiruchinapalli DM; Caron MG; Keene JD
    J Neurochem; 2008 Dec; 107(6):1529-43. PubMed ID: 19014379
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.
    Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P
    Cancer; 2002 Feb; 94(3):854-61. PubMed ID: 11857322
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overexpression of HuD accelerates neurite outgrowth and increases GAP-43 mRNA expression in cortical neurons and retinoic acid-induced embryonic stem cells in vitro.
    Anderson KD; Sengupta J; Morin M; Neve RL; Valenzuela CF; Perrone-Bizzozero NI
    Exp Neurol; 2001 Apr; 168(2):250-8. PubMed ID: 11259113
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma.
    Islam A; Kageyama H; Takada N; Kawamoto T; Takayasu H; Isogai E; Ohira M; Hashizume K; Kobayashi H; Kaneko Y; Nakagawara A
    Oncogene; 2000 Feb; 19(5):617-23. PubMed ID: 10698506
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ELAV tumor antigen, Hel-N1, increases translation of neurofilament M mRNA and induces formation of neurites in human teratocarcinoma cells.
    Antic D; Lu N; Keene JD
    Genes Dev; 1999 Feb; 13(4):449-61. PubMed ID: 10049360
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Somatostatin receptor type 2 gene expression in neuroblastoma, measured by competitive RT-PCR, is related to patient survival and to somatostatin receptor imaging by indium -111-pentetreotide.
    Orlando C; Raggi CC; Bagnoni L; Sestini R; Briganti V; La Cava G; Bernini G; Tonini GP; Pazzagli M; Serio M; Maggi M
    Med Pediatr Oncol; 2001 Jan; 36(1):224-6. PubMed ID: 11464890
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuroblastoma in the first year of life: clinical and biologic factors influencing outcome.
    Grosfeld JL; Rescorla FJ; West KW; Goldman J
    Semin Pediatr Surg; 1993 Feb; 2(1):37-46. PubMed ID: 8062021
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel products of the HUD, HUC, NNP-1 and alpha-internexin genes identified by autologous antibody screening of a pediatric neuroblastoma library.
    Behrends U; Jandl T; Golbeck A; Lechner B; Müller-Weihrich S; Schmid I; Till H; Berthold F; Voltz R; Mautner JM
    Int J Cancer; 2002 Aug; 100(6):669-77. PubMed ID: 12209604
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of HuD (a paraneoplastic encephalomyelitis antigen) mRNA in lung cancer.
    Cho JH; Noguchi M
    J Korean Med Sci; 1997 Aug; 12(4):305-10. PubMed ID: 9288629
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increase of the RNA-binding protein HuD and posttranscriptional up-regulation of the GAP-43 gene during spatial memory.
    Pascale A; Gusev PA; Amadio M; Dottorini T; Govoni S; Alkon DL; Quattrone A
    Proc Natl Acad Sci U S A; 2004 Feb; 101(5):1217-22. PubMed ID: 14745023
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The TH, ELAVL4 and GD2 gene expression as diagnostic markers of bone marrow lesions in patients with neuroblastoma].
    Druĭ AE; Tsaur GA; Popov AM; Tuponogov SN; Shorikov EV; Tsvirenko SV; Savel'ev LI; Fechina LG
    Vopr Onkol; 2012; 58(4):514-20. PubMed ID: 23607207
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system.
    Thompson PM; Gotoh T; Kok M; White PS; Brodeur GM
    Oncogene; 2003 Feb; 22(7):1002-11. PubMed ID: 12592387
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Paraneoplastic encephalomyelitis antigens bind to the AU-rich elements of mRNA.
    Liu J; Dalmau J; Szabo A; Rosenfeld M; Huber J; Furneaux H
    Neurology; 1995 Mar; 45(3 Pt 1):544-50. PubMed ID: 7898713
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DNA vaccination against HuD antigen elicits antitumor activity in a small-cell lung cancer murine model.
    Ohwada A; Nagaoka I; Takahashi F; Tominaga S; Fukuchi Y
    Am J Respir Cell Mol Biol; 1999 Jul; 21(1):37-43. PubMed ID: 10385591
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of bcl-2 gene product in neuroblastoma.
    Ramani P; Lu QL
    J Pathol; 1994 Mar; 172(3):273-8. PubMed ID: 8195931
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Insulin-like growth factor II mRNA-binding protein 3 expression predicts unfavorable prognosis in patients with neuroblastoma.
    Chen ST; Jeng YM; Chang CC; Chang HH; Huang MC; Juan HF; Hsu CH; Lee H; Liao YF; Lee YL; Hsu WM; Lai HS
    Cancer Sci; 2011 Dec; 102(12):2191-8. PubMed ID: 21917080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.